AllInBio
2 known investors
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
Investors · 2
Frequently asked questions
- What does AllInBio do?
- ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
- Who are AllInBio's investors?
- AllInBio's investors include +ND Capital, Artis Ventures.